Ann Oncol : Off J Eur Soc Med Oncol 29:2068–2075 Kron A, Alidousty C, Scheffler M et al (2018) Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer. The gene discussed is ALK; the disease is non-small cell lung carcinoma.